Kennedy Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Sell |
47,294
-1,855
| -4% | -$130K | 0.08% | 358 |
|
|
2025
Q1 | $3.61M | Sell |
49,149
-5,938
| -11% | -$436K | 0.09% | 340 |
|
|
2024
Q4 | $3.61M | Buy |
55,087
+35,977
| +188% | +$2.36M | 0.08% | 390 |
|
|
2024
Q3 | $1.49M | Buy |
19,110
+3,070
| +19% | +$239K | 0.03% | 552 |
|
|
2024
Q2 | $1.25M | Buy |
16,040
+2,552
| +19% | +$199K | 0.03% | 569 |
|
|
2024
Q1 | $914K | Buy |
+13,488
| New | +$914K | 0.02% | 625 |
|